Stocksigma LogoStocksigma Logo

Dishman Carbogen Amcis Subsidiary Clears US FDA Inspection with Zero Observations

Dishman Carbogen Amcis Limited announced that its wholly owned subsidiary, CARBOGEN AMCIS AG, has successfully completed its maiden US FDA inspection at

Dishman Carbogen Amcis Subsidiary Clears US FDA Inspection with Zero Observations

Dishman Carbogen Amcis Ltd 路 Others (Uncategorized) 路 12 Sept 2026, 10:01 pm

Dishman Carbogen Amcis Subsidiary Clears US FDA Inspection with Zero Observations Dishman Carbogen Amcis Limited announced that its wholly owned subsidiary, CARBOGEN AMCIS AG, has successfully completed its maiden US FDA inspection at its manufacturing facility in Vionnaz, Switzerland. The regulatory audit concluded on 11th Sep'26 with zero observations and no issuance of Form 483, reaffirming strong compliance and quality standards across the company's global manufacturing footprint.

Original exchange filing (PDF)

More announcements from Dishman Carbogen Amcis Ltd

All Dishman Carbogen Amcis Ltd announcements